Adjuvant treatment for colorectal cancer

doi:10.1136/bmj.312.7043.1417

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Reducing avoidable delays in establishing the diagnosis is also important

Guru Aithal,
Andrew Tanner

Medical registrar Consultant physician North Tees General Hospital, Stockton TS19 8PE

EDITOR,—In patients with colorectal cancer,1 any measures that reduce the delay to diagnosis should, hopefully, improve surgical cure rates and reduce the need for adjuvant treatment. There is good evidence from studies2 3 and from epidemiological publications4 to suggest that better application of proved methodologies would improve the detection of colorectal cancer at an early and more favourable stage.

We recently completed a study of the diagnostic delays for all colorectal cancers presenting …